Jan 30, 2026 | News, Press Review
From TG3 Leonardo to national media: press recognition supports Hemera’s path toward the clinical phase Following the recent publication in the prestigious international journal Immunity by Cell Press of data related to the REMaST® cell therapy, Hemera is pleased to...
Jan 26, 2026 | News, Press Releases
A peer-reviewed study demonstrates the therapeutic potential of REMaST® in spinal cord repair and neuronal regeneration Hemera is pleased to announce the online preprint publication of the manuscript “Tumor-associated macrophages enhance peripheral nerve tumor...